We are live on ! Find out more
FC

Fore Capital Portfolio holdings

AUM $338M Turnover 62.67%
1-Year Est. Return 10.07%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
–
AUM
$80.7M
AUM Growth
-$14.9M
Cap. Flow
-$21M
Cap. Flow %
-26.04%
Top 10 Hldgs %
90.39%
Holding
33
New
5
Increased
1
Reduced
4
Closed
9
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
BLCO icon
Bausch + Lomb
BLCO
+$844K
2
DFTX icon
Definium Therapeutics
DFTX
+$358K

Top Sells

Rank Stock Value
1
SILC icon
Silicom
SILC
+$415K
2
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$226K
3
PGEN icon
Precigen
PGEN
+$211K
4
BMRA icon
Biomerica
BMRA
+$108K

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.48%
2 Healthcare 1.98%
3 Technology 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$33.9M 42.07%
+95,000
New +$37.7M
2022 Q3
0 quarters
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$12.5M 15.5%
+35,000
New +$13.9M
2022 Q3
0 quarters
SLV icon
3
CALL
iShares Silver Trust
SLV
$27.7B
$7M 8.68%
400,000
-60,000
-13% -$1.06M
2017 Q4
19 quarters
SILC icon
4
Silicom
SILC
$250M
$1.24M 1.53%
35,000
-10,776
-24% -$415K
2021 Q3
4 quarters
BLCO icon
5
Bausch + Lomb
BLCO
$5.87B
$815K 1.01%
+53,142
New +$844K
2022 Q3
0 quarters
PGEN icon
6
Precigen
PGEN
$2.67B
$413K 0.51%
195,000
-100,000
-34% -$211K
2022 Q1
2 quarters
OPTU icon
7
CALL
Optimum Communications Inc
OPTU
$350M
$292K 0.36%
+50,000
New +$479K
2022 Q3
0 quarters
GDX icon
8
CALL
VanEck Gold Miners ETF
GDX
$25.8B
$241K 0.3%
+10,000
New +$253K
2022 Q3
0 quarters
BMRA icon
9
Biomerica
BMRA
$8.6M
$203K 0.25%
6,460
-4,165
-39% -$108K
2021 Q1
6 quarters
DFTX icon
10
Definium Therapeutics
DFTX
$4.66B
$168K 0.21%
47,999
+37,332
+350% +$358K
2022 Q1
2 quarters
FUBO icon
11
CALL
FuboTV Inc
FUBO
$261M
– –
-4,167
Closed -$124K –
FUBO icon
12
PUT
FuboTV Inc
FUBO
$261M
– –
-16,575
Closed -$491K –
GLD icon
13
CALL
SPDR Gold Trust
GLD
$141B
– –
-175,000
Closed -$29.5M –
HYG icon
14
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
– –
-150,000
Closed -$11M –
NUGT icon
15
CALL
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$954M
– –
-170,000
Closed -$5.84M –
REAL icon
16
CALL
The RealReal
REAL
$1.25B
– –
-75,700
Closed -$188K –
REAL icon
17
PUT
The RealReal
REAL
$1.25B
– –
-135,000
Closed -$336K –
STNG icon
18
PUT
Scorpio Tankers
STNG
$4.17B
– –
-15,000
Closed -$518K –
WFC.PRL icon
19
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.29B
– –
-186
Closed -$226K –

Similar funds

Fore Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Fore Capital held 33 positions worth $80.7M, down 16% from $95.5M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Fore Capital withdrew a net $21M in Q3 2022, closing 9 positions and reducing 4 holdings. Its most notable exit was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $226K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, down from 98% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Fore Capital opened a new position in Bausch + Lomb worth $815K.

  • Fore Capital's largest Q3 2022 buy was Bausch + Lomb: 53,142 shares worth $815K.
  • Fore Capital added most to Definium Therapeutics in Q3 2022, an estimated $358K increase.
  • Fore Capital's biggest Q3 2022 reduction was Silicom, cutting an estimated $415K.
  • Fore Capital fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q3 2022, selling an estimated $226K.
  • Fore Capital's ten largest holdings make up 90% of its $80.7M portfolio in Q3 2022.
  • Fore Capital opened 5 new positions and closed 9 in Q3 2022.
  • Fore Capital's portfolio value fell 16% quarter-over-quarter to $80.7M.

Based on Fore Capital's 13F filing for Q3 2022, filed 10 Nov 2022.